GENMAB A/S (GMAB)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

3 annual periodsNewest to oldest
201920182017
Revenuekr5.37Bkr3.02Bkr2.37B
Research & developmentkr2.39Bkr1.43Bkr874.0M
Operating expenseskr2.73Bkr1.65Bkr1.02B
Operating incomekr2.64Bkr1.38Bkr1.34B
EBITDAderivedkr2.68Bkr1.41Bkr1.36B
Net incomekr2.17Bkr1.47Bkr1.10B
Basic EPSper diluted shareDKK 34.40DKK 24.03DKK 18.14
Diluted EPSper diluted shareDKK 34.03DKK 23.73DKK 17.77

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.